HDAC3 and acute promyelocytic leukemia: Co‐depletion of Hdac1 with Hdac2 facilitates a pro‐apoptotic response that is robust; HDAC3 inhibitor RGFP966 decreased Eμ‐Myc lymphoma proliferation and differentiation in APL